Summit Therapeutics Share Discussion Threads

[kirk 6] 17/6/2019 21:23

Nice rally over on the Nasdaq about time too

[chrisatrdg] 17/6/2019 12:11

Agronomics Ltd
Half-year Report

It includes a good piece on Summit so he is still holding Summit shares.

[chrisatrdg] 17/6/2019 10:57

The next RNS

Could we be in for a surprise RNS soon in which it is announced that Summit will receive further funding for their C-Diff trials based on recent articles for the need to combat diseases like C-Diff there was a final realisation that their drug must succeed & so funds provided.Just a thought.

[waterloo01] 16/6/2019 17:50

I continue to wonder about the effect on the rest of the microbiome.

FDA In Brief: FDA warns about potential risk of serious infections caused by multi-drug resistant organisms related to the investigational use of Fecal Microbiota for Transplantation

[waterloo01] 15/6/2019 09:31

Wonder if Port Erin (Mellon's vehicle) now called Argonomics will increase stake or are sellers?

[waterloo01] 15/6/2019 07:09

good finds.

[chrisatrdg] 14/6/2019 23:16

FDA issues warning after patient dies from fecal transplant containing drug-resistant bacteria

[chrisatrdg] 14/6/2019 23:01

Fighting antimicrobial resistance & making the EU a best practice region remains top priority in the area of health, agree EU ministers on day 2 of the #EPSCO.

[chrisatrdg] 13/6/2019 15:47

Summit Therapeutics 'taking leadership role' in development of new antibiotics

investors.co.uk/companies/stocktube/13726/summit-therapeutics--taking-leadership-role--in-development-of-new-antibiotics-13726.html

[chrisatrdg] 12/6/2019 21:19

A Critical Juncture for Antibiotic R&D
Jun 11, 2019
By David Roblin
Pharmaceutical Executive
Volume 39, Issue 6

[kirk 6] 12/6/2019 19:24

Got big stakes in quite a few stocks so haven't got the time soo busy trading

[waterloo01] 12/6/2019 18:52

Well you are going to have to be patient to see a return (or an exit). You should attend the AGM and get to know your investment

[kirk 6] 12/6/2019 18:21

Hold well over 1mI'm sure there has recently been a £1.50 price target (will take a look later)Also the 25p equivalent funder will want a return and all the options at 29.5p will want to be exercised

[waterloo01] 12/6/2019 17:54

kirk6, how many shares do you own? Who's £1.50 price target?

No the phase 3's are expensive and while they have up to $62m from Barda, there is a funding gap. The C.diff trial won't report till 2021. Might find partner, but seems unlikely unless the whole antimicrobial s space improves, or other sources of funding for other targets or get grants etc.

I just expected it to be well into 2020 before funds needed and time to 'mine' the options. Maybe they are being super cautious?

[kirk 6] 12/6/2019 17:46

Less spend tho and just under 28m in cash surely if the trials are successful Summ can partner?!?What about the recent £1.50 share price target ?

[waterloo01] 12/6/2019 16:43

I'm not that pessimistic and have few worries that the company can get the funding needed, so not concerned about it's 'existence' just the cost in dilution, unless ANO Barda type options? Not past them to pull that off.

[chrisatrdg] 12/6/2019 16:29

I agree with waterloo01 the principal matter of note is the delay to SMT 751 but also they have said that there is now also added the following under the Notes to the Accounts - Note 1 Basis of Accounting

'Should the Group be unable to raise additional funding, management has the ability to take mitigating action to fund its operating expenses and capital expenditure requirements in relation to its clinical development activities for only a short period beyond 12 months from the date of issuance of these financial statements.'

The above says there are contingency plans to extend the ability of the Company to trade beyond 31st January 2020 & may tie in to another reason for delaying on SMT751.The date becomes 12 months from the 12th June 2019 as the final date they could go to then its good night Vienna.

[waterloo01] 12/6/2019 15:15

Well a mixed bag I guess. SMT 751 trial date delayed but they hope as a result will be a quicker trial once it starts. I suspect it's as much to do with cash preservation as only have cash till end January 2020, despite having £28m in cash end April and money due from carbX and Barda.

Let's hope there are enough grants etc out there to fund going forward as not sure an equity raise is particularly welcome, although last time they raised at a premium, but the dilution was chunky.

Still Nasdaq don't like it!

Edit: and now it does!

[kirk 6] 12/6/2019 13:48

Reduced loss and exciting future ?

[chrisatrdg] 10/6/2019 20:01

AGM

I will see you there waterloo01 & I am looking forward to some of your questions.Regards

PS INFA starting to move up again I hope to be in a better place by next week.

[waterloo01] 10/6/2019 19:18

Haven't decided yet, but a few other posters know who I am. I usually like to ask questions!

[algernon2] 10/6/2019 19:05

It'll be good to meet you Waterloo, how will I know you? Will you be suited or carrying a rolled up umbrella or have a giant Moustache?

[waterloo01] 10/6/2019 18:24

I'm going.

[algernon2] 10/6/2019 18:17

Anyone off to the AGM next week. I will either be attending this one at 10 am next Wednesday or the Midatech Pharma one at 11 00 am same day.Not totally decided yet. Would be good to meet some other of you there however.